Factor | Lin2017 (10039)

Enrofloxacin use

Swine | Weaners

8

Description

Gavaged with a therapeutic dosage of enrofloxacin at 10 mg/kg of body weight once per day for 7 days.

Resistance Outcomes

Resistance Microbe Outcome
Cefotaxime
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 5.00 50
No use 0.00 50
Ciprofloxacin
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 40.00 50
No use 0.00 50
Kanamycin
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 60.00 50
No use 15.00 50
Ceftriaxone
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 5.00 50
No use 0.00 50
Tetracycline
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 100.00 50
No use 100.00 50
Chloramphenicol
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 100.00 50
No use 75.00 50
Nalidixic Acid
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 100.00 50
No use 80.00 50
Gentamicin
/
Escherichia coli
See: Table 1 AMR+ (%) AMR- (%) Total (n)
Enrofloxacin use 20.00 50
No use 5.00 50